Dr. Zhang’s research program focuses on investigating the key physiological and pathological roles of the Nrf2-Keap1-ARE signaling pathway in mediating disease. She has published over 130 well-received papers as evidenced by her total number of citations (26745) and h-index (63). Dr. Zhang has made seminal contributions to both the mechanistic understanding of Nrf2 regulation, as well as the dual role of Nrf2 in human diseases. Her work has been continuously supported by the NIH, and is both nationally and internationally recognized, including in 2012 when she received the Society of Toxicology Achievement Award.